PURE Bioscience Names CFO
, the developer of antimicrobial agents, said Thursday that it has named Peter C. Wulff as its Chief Financial Officer. Wulff was previously at Alphatec Holdings, and also has served at such firms as Artes Medical, CryoCor, and Natural Alternatives International. PURE Bioscience said Wulff has 25 years of experience in the industry.
posted on Friday, November 9, 2012
> Pure Bioscience In India Distribution Deal
> PURE Bioscience Names VP
> PURE Bioscience Gets $2.376M In PIPE
> PURE Bioscience Expands Board
> Abraxis BioScience Names CFO